Evidence map›Paper›PMID 28698273›Full record

ArticlemBio2017

Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.

Anna K P Serquiña, Diane M Kambach, Ontara Sarker, Joseph M Ziegelbauer

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. 25-Hydroxycholesterol in health and diseases.Journal of lipid research · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. TemporalACS omega · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. Curbing Lipids: Impacts ON Cancer and Viral Infection.International journal of molecular sciences · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anna K P SerquiñaHIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-5629-6099
Diane M KambachRadiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Ontara SarkerHIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Joseph M ZiegelbauerHIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA ziegelbauerjm@mail.nih.gov.ORCID 0000-0001-6464-6941
National Institutes of Health · US

Funding

Functions of KSHV microRNAs and circular RNAsZIABC011176 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZIEGELBAUER, JOSEPH · 2009 to 2025
$14.0M
Intramural NIH HHS ZIA BC011176
6 · The paper itself

Abstract

From various screens, we found that Kaposi's sarcoma-associated herpesvirus (KSHV) viral microRNAs (miRNAs) target several enzymes in the mevalonate/cholesterol pathway. 3-Hydroxy-3-methylglutaryl-coenzyme A (CoA) synthase 1 (HMGCS1), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR [a rate-limiting step in the mevalonate pathway]), and farnesyl-diphosphate farnesyltransferase 1 (FDFT1 [a committed step in the cholesterol branch]) are repressed by multiple KSHV miRNAs. Transfection of viral miRNA mimics in primary endothelial cells (human umbilical vein endothelial cells [HUVECs]) is sufficient to reduce intracellular cholesterol levels; however, small interfering RNAs (siRNAs) targeting only HMGCS1 did not reduce cholesterol levels. This suggests that multiple targets are needed to perturb this tightly regulated pathway. We also report here that cholesterol levels were decreased in

Indexed as

Acyl Coenzyme ACell LineCholesterolEndothelial CellsGene Expression Regulation, ViralHerpesvirus 8, HumanHost-Pathogen InteractionsHumansHydroxycholesterolsMetabolic Networks and PathwaysMicroRNAsReal-Time Polymerase Chain ReactionRNA, Small InterferingRNA, ViralSteroid HydroxylasesVirus Latency25-hydroxycholesterol3-hydroxy-3-methylglutaryl-coenzyme AAcyl Coenzyme ACholesterolcholesterol 25-hydroxylaseHydroxycholesterolsMicroRNAsRNA, Small InterferingRNA, ViralSteroid Hydroxylasescholesterolhuman herpesvirusesKaposi's sarcoma-associated herpesvirusmicroRNA

Identifiers

PMID28698273
PMCPMC5513709
OpenAlexW2735220104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.